|
"許駿"的相關文件
顯示項目 81-90 / 148 (共15頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2010 |
Design, Translation, and Test of Multi-Dimensional Questionnaires
|
季瑋珠; 許駿; 章殷超; 程劭儀; 高芷華; CHIE, WEI-CHU; HSU, CHIUN; Y.C.CHANG; CHEN, G SHAO-YI; KAO, TZE-WAH |
| 國立臺灣大學 |
2010 |
Potentiating the Anti-Tumor Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Signaling Pathway
|
歐大諒; 許駿; 沈盈君; 鄭安理; OU, DA-LIANG; HSU, CHIUN; SHEN, YING-CHUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
The Aurora Kinase Inhibitor Ve-465 Has Anticancer Effects in Pre-Clinical Studies of Human Hepatocellular Carcinoma
|
許輝吉; 徐志宏; 葉培彥; 黃繼瑩; 郭頌鑫; 許駿; 胡賦強; 鄭永銘; 鄭安理; HSU, HEY-CHI; HSU, CHIH-HUNG; YEH, PEI-YEN; HUANG, CHI-YING; KUO, SUNG-HSIN; HSU, CHIUN; HU, FU-CHANG; JENG, YUNG-MING; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Nuclear Overexpression of Mitotic Regulatory Proteins in Biliary Tract Cancer: Correlation with Clinicopathologic Features and Patient Survival
|
沈盈君; 胡賦強; 鄭永銘; 張毓廷; 林宗哲; 章明珠; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG-MING; CHANG, YU-TING; LIN, ZONG-ZHE; CHANG, MING-CHU; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
INDUCTION OF BIM EXPRESSION CONTRIBUTES TO THE ANTITUMOR SYNERGY BETWEEN SORAFENIB AND MITOGEN-ACTIVATED PROTEIN KINASE/EXTRACELLULAR SIGNAL-REGULATED KINASE KINASE INHIBITOR CI-1040 IN HEPATOCELLULAR CARCINOMA
|
歐大諒; 沈盈君; 梁嘉德; 劉俊陽; 俞松良; 盧彥伸; 許駿 |
| 國立臺灣大學 |
2009 |
Induction of Bim Expression Contributes to the Antitumor Synergy between Sorafenib and Mitogen-Activated Protein Kinase/Extracellular Signal- Regulated Kinase Kinase Inhibitor Ci-1040 in Hepatocellular Carcinoma
|
歐大諒; 沈盈君; 梁嘉德; 劉俊揚; 俞松良; 盧彥伸; 許駿; 鄭安理; OU, DA-LIANG; SHEN, YING-CHUN; LIANG, JA-DER; LIOU, JUN-YANG; YU, SUNG-LIANG; LU, YEN-SHEN; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Overexpressed Focal Adhesion Kinase Predicts a Higher Incidence of Extrahepatic Metastasis and Worse Survival in Hepatocellular Carcinoma
|
詹以吉; 柯博升; 許駿; 王約翰; 劉俊揚; JAN, YEE-JEE; KO, BO-SHENG; HSU, CHIUN; WANG, JOHN; LIOU, JUN-YANG |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Bevacizumab (B) and Erlotinib (E) in Combination for Asian Patients (Pts) with Advanced/Metastatic Hepatocellular Carcinoma ( Hcc): An Interim Safety Report
|
徐志宏; 邱宗傑; 許駿; 鄭安理; HSU, CHIH-HUNG; CHIOU, TZEON-JYE; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Study of Sorafenib in Combination with Tegafur/Uracil (Uft) for Asian Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 許駿; 徐志宏; 林宗哲; 陳培哲; 邵幼雲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; HSU, CHIUN; HSU, CHIH-HUNG; LIN, ZONG-ZHE; CHEN, PEI-JER; SHAO, YU-YUN; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
A Phase Ii Trial of Thalidomide Plus Tegafur/Uracil for Patients with Advanced/Metastatic Hepatocellular Carcinoma (Hcc): Final Report
|
徐志宏; 林宗哲; 沈盈君; 許駿; 鄭安理; HSU, CHIH-HUNG; LIN, ZONG-ZHE; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII |
顯示項目 81-90 / 148 (共15頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目
|
